News & Events

Meet with the Demeetra team at Booth #511 to chat about the latest development strategies in mosquito control and to gain an intimate understanding of our cutting-edge larvicidal research.55

The 5th Annual CRISPR AgBio Congress will unite research leaders, molecular biologists, regulatory experts, and product developers across the industry working to translate cutting-edge CRISPR technology into a tangible product.

The 5th Annual CRISPR AgBio Congress will unite research leaders, molecular biologists, regulatory experts, and product developers across the industry working to translate cutting-edge CRISPR technology into a tangible product.55

PAG30 is the premier and largest Ag genomics meeting in the world. Meet us there to learn how our gene editing tools, Cas-CLOVER nuclease and piggyBac transposase can enable research and commercial product development.

PAG30 is the premier and largest Ag genomics meeting in the world. Meet us there to learn how our gene editing tools, Cas-CLOVER nuclease and piggyBac transposase can enable research and commercial product development.55

For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocessing. Meet our team in Boston to chat about the latest studies or to gain an intimate understanding of our cutting edge gene editing technology.

For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocessing. Meet our team in Boston to chat about the latest studies or to gain an intimate understanding of our cutting edge gene editing technology.55

BioProcess International is the largest bioprocessing event for learning how to accelerate promising biologics, cell & gene therapies toward commercial success. Join us for a presentation discussing the implementation of Cas-CLOVER for cell line development.

BioProcess International is the largest bioprocessing event for learning how to accelerate promising biologics, cell & gene therapies toward commercial success. Join us for a presentation discussing the implementation of Cas-CLOVER for cell line development.55